Riverside Medical Center

Patient Safety - All

Healthcare-Associated Infections

Hospitals in Illinois are participating in programs to reduce the number of infections acquired during hospital stays. While it is difficult to reduce infections to zero, following specific protocols can greatly reduce the risk.

The Hospital Report Card Act (Illinois Public Act 93-563) requires Illinois hospitals to report central line associated bloodstream infections (CLABSIs) as well as surgical site infections (SSIs). As of January 1, 2012, hospitals are also mandated to report Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections and Clostridioides difficileinfections. Infections are reported through the CDC’s National Healthcare Safety Network (NHSN) surveillance system. The Standardized Infection Ratio (SIR), a summary measure used to determine whether infection data are statistically different from the national average, is presented for each type of infection shown below. Read more about healthcare-associated infections in Illinois. To learn more about the data collection methods using the CDC's National Health Safety Network (NHSN) surveillance system, read the Report Card methodology.

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
32	Complete Reporting: Unit Operational Limited Time
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
43	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Central Line Associated Bloodstream Infections (CLABSIs)

Presented below are annual central line-associated bloodstream infections (CLABSIs) occurring in critical care units, also known as intensive care units (ICUs). ICU-specific summary data for CLABSI are provided using the Standardized Infection Ratio(SIR). Statewide summaries of CLABSI data arranged by ICU type and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
32	Complete Reporting: Unit Operational Limited Time
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
43	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Adult CLABSI

Pediatric CLABSI

Ped. CLABSI Measure	Result	SIR
Pediatric Medical-Surgical ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection (CLABSI) data in the Medical-Surgical Pediatric ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q4 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: 0.00 ³⁸	N/A infections, N/A central-line days ³⁸	0.00 ³⁸

NICU CLABSI

NICU CLABSI Measure	Result	SIR
Level III Neonatal ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection data in the Level III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2010 - Q4 2010 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹

Surgical Site Infections (SSIs)

Presented below are data for surgical site infections associated with coronary artery bypass graft surgery (CABG) and total knee replacement surgery (KPROs) using the Standardized Infection Ratio (SIR). Superficial and secondary surgical site infections are not included in the summary data below. Statewide summaries of surgical site infection data arranged by surgical procedure (CABG, KPRO) and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
32	Complete Reporting: Unit Operational Limited Time
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
43	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Immunization Practices

Illinois hospitals are focusing their efforts on boosting immunization treatments and strengthening patient safety protocols. The objective is not merely achieving statistical success, but also enhancing the quality of care and patient well-being.

Data on immunization measures in Illinois hospitals is available through the Medicare comparison tool at medicare.gov/hospitalcompare. This tool provides valuable insights, allowing patients and their families to gauge the quality of care and safety practices at local hospitals, helping them make informed healthcare decisions.

In the realm of Patient Safety, a host of measures are assessed, with risk-adjusted rates available for each. These measures encompass various aspects of patient care and treatment outcomes. However, interpreting these metrics requires an understanding of the complexity and context-specific nature of healthcare.

Immunization

These indicators are used to measure immunization treatments at hospitals. This data comes from medicare.gov/hospitalcompare.

Measure	Result
Healthcare workers given influenza vaccination Q4 2022 - Q1 2023 Result 98.00 %	98.00 %
Description Influenza Vaccination Coverage among Healthcare Personnel Historical Data
Measure	Result
Q4 2021 - Q1 2022 Result 98.00 %	98.00 %
Q4 2020 - Q1 2021 Result 99.00 %	99.00 %
Q4 2019 - Q1 2020 Result 99.00 %	99.00 %
Q4 2018 - Q1 2019 Result 96.00 %	96.00 %
Q4 2017 - Q1 2018 Result 95.00 %	95.00 %

Illinois Hospital Report Card

and Consumer Guide to Health Care

Riverside Medical Center

Patient Safety - All

Healthcare-Associated Infections

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Central Line Associated Bloodstream Infections (CLABSIs)

Statistical Significance

Footnotes

Adult CLABSI

Description

Historical Data

Description

Historical Data

Pediatric CLABSI

Description

Historical Data

NICU CLABSI

Description

Historical Data

Surgical Site Infections (SSIs)

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Immunization Practices

Immunization

Description

Historical Data

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 0 infections, 41974 patient days Rating SIR: 0.00	0 infections, 41974 patient days	0.00
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 2 infections, 43300 patient days Rating SIR: 0.79	2 infections, 43300 patient days	0.79
Q1 2021 - Q4 2021 Result 1 infections, 50970 patient days Rating SIR: 0.37	1 infections, 50970 patient days	0.37
Q1 2020 - Q4 2020 Result 1 infections, 48215 patient days Rating SIR: 0.42	1 infections, 48215 patient days	0.42
Q1 2019 - Q4 2019 Result 2 infections, 53606 patient days Rating SIR: 0.92	2 infections, 53606 patient days	0.92
Q1 2018 - Q4 2018 Result 4 infections, 56572 patient days Rating SIR: 1.51	4 infections, 56572 patient days	1.51
Q1 2017 - Q4 2017 Result 1 infections, 55512 patient days Rating SIR: 0.38	1 infections, 55512 patient days	0.38
Q1 2016 - Q4 2016 Result 1 infections, 61050 patient days Rating SIR: 0.37	1 infections, 61050 patient days	0.37
Q1 2015 - Q4 2015 Result 2 infections, 52531 patient days Rating SIR: 0.62	2 infections, 52531 patient days	0.62
Q1 2014 - Q4 2014 Result 0 infections, 58475 patient days Rating SIR: 0.00	0 infections, 58475 patient days	0.00
Q1 2013 - Q4 2013 Result 2 infections, 60872 patient days Rating SIR: 0.56	2 infections, 60872 patient days	0.56
Q1 2012 - Q4 2012 Result 2 infections, 60014 patient days Rating SIR: 0.67	2 infections, 60014 patient days	0.67
Q1 2012 - Q2 2012 Result 0 infections, 30912 patient days Rating SIR: 0.00	0 infections, 30912 patient days	0.00
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 10 infections, 40583 patient days Rating SIR: 0.40	10 infections, 40583 patient days	0.40
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 14 infections, 41914 patient days Rating SIR: 0.53	14 infections, 41914 patient days	0.53
Q1 2021 - Q4 2021 Result 22 infections, 49392 patient days Rating SIR: 0.68	22 infections, 49392 patient days	0.68
Q1 2020 - Q4 2020 Result 14 infections, 46397 patient days Rating SIR: 0.48	14 infections, 46397 patient days	0.48
Q1 2019 - Q4 2019 Result 25 infections, 51195 patient days Rating SIR: 0.76	25 infections, 51195 patient days	0.76
Q1 2018 - Q4 2018 Result 52 infections, 54280 patient days Rating SIR: 1.31	52 infections, 54280 patient days	1.31
Q1 2017 - Q4 2017 Result 18 infections, 53184 patient days Rating SIR: 0.50	18 infections, 53184 patient days	0.50
Q1 2016 - Q4 2016 Result 25 infections, 58719 patient days Rating SIR: 0.67	25 infections, 58719 patient days	0.67
Q1 2015 - Q4 2015 Result 26 infections, 50246 patient days Rating SIR: 0.56	26 infections, 50246 patient days	0.56
Q1 2014 - Q4 2014 Result 25 infections, 57816 patient days Rating SIR: 0.49	25 infections, 57816 patient days	0.49
Q1 2013 - Q4 2013 Result 26 infections, 60872 patient days Rating SIR: 0.47	26 infections, 60872 patient days	0.47
Q1 2012 - Q4 2012 Result 33 infections, 58583 patient days Rating SIR: 0.68	33 infections, 58583 patient days	0.68

Adult CLABSI Measure	Result	SIR
Adult Medical/Surgical ICU Q1 2023 - Q4 2023 Result 0 infections, 1486 central-line days Rating SIR: 0.00	0 infections, 1486 central-line days	0.00
Description Central Line-associated Bloodstream Infection data in the Adult Medical/Surgical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 0 infections, 1815 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1815 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2021 - Q4 2021 Result 2 infections, 2360 central-line days Rating SIR: 0.75	2 infections, 2360 central-line days	0.75
Q1 2020 - Q4 2020 Result 3 infections, 1930 central-line days Rating SIR: 1.38	3 infections, 1930 central-line days	1.38
Q1 2019 - Q4 2019 Result 2 infections, 1349 central-line days Rating SIR: 1.31	2 infections, 1349 central-line days	1.31
Q1 2018 - Q4 2018 Result 2 infections, 1645 central-line days Rating SIR: 1.08	2 infections, 1645 central-line days	1.08
Q1 2017 - Q4 2017 Result 2 infections, 1498 central-line days Rating SIR: 1.18	2 infections, 1498 central-line days	1.18
Q1 2016 - Q4 2016 Result 0 infections, 1576 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1576 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2015 - Q4 2015 Result 1 infections, 1882 central-line days Rating SIR: 0.25	1 infections, 1882 central-line days	0.25
Q1 2014 - Q4 2014 Result 0 infections, 497 central-line days ³² Rating SIR: 0.00 ³²	0 infections, 497 central-line days ³²	0.00 ³²
Q1 2013 - Q4 2013 Result 3 infections, 1489 central-line days Rating SIR: 0.96	3 infections, 1489 central-line days	0.96
Q1 2012 - Q4 2012 Result 2 infections, 1175 central-line days Rating SIR: 1.13	2 infections, 1175 central-line days	1.13
Q1 2011 - Q4 2011 Result 0 infections, 1576 central-line days ⁴³ Rating SIR: 0.00 ⁴³	0 infections, 1576 central-line days ⁴³	0.00 ⁴³
Q1 2010 - Q4 2010 Result 0 infections, 1436 central-line days ⁴³ Rating SIR: 0.00 ⁴³	0 infections, 1436 central-line days ⁴³	0.00 ⁴³
Q1 2009 - Q4 2009 Result 2 infections, 1671 central-line days Rating SIR: 0.80	2 infections, 1671 central-line days	0.80
Q1 2009 - Q2 2009 Result 0 infections, 716 central-line days Rating SIR: 0.00	0 infections, 716 central-line days	0.00
Adult Medical/Surgical ICU, Second Unit Q1 2014 - Q4 2014 Result N/A infections, 497 central-line days ³² Rating SIR: 0.00 ³²	N/A infections, 497 central-line days ³²	0.00 ³²
Description Central Line-associated Bloodstream Infection data in the Medical/Surgical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2013 - Q4 2013 Result 1 infections, 1108 central-line days Rating SIR: 0.43	1 infections, 1108 central-line days	0.43
Q1 2012 - Q4 2012 Result 3 infections, 1524 central-line days Rating SIR: 1.31	3 infections, 1524 central-line days	1.31
Q1 2011 - Q4 2011 Result 1 infections, 1897 central-line days Rating SIR: 0.48	1 infections, 1897 central-line days	0.48
Q1 2009 - Q4 2009 Result 0 infections, 1281 central-line days Rating SIR: 0.00	0 infections, 1281 central-line days	0.00

SSI Measure	Result	SIR
Total Knee Replacement Surgery Q1 2020 - Q4 2020 Result 0 infections, 53 procedures ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 53 procedures ¹¹⁸	N/A ¹¹⁸
Description Surgical Site Infections Associated with Total Knee Replacement Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2019 - Q4 2019 Result 0 infections, 131 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 131 procedures ¹⁵³	N/A ¹⁵³
Q1 2018 - Q4 2018 Result 3 infections, 188 procedures ¹¹⁴ Rating SIR: N/A ¹¹⁴	3 infections, 188 procedures ¹¹⁴	N/A ¹¹⁴
Q1 2017 - Q4 2017 Result 1 infections, 243 procedures Rating SIR: 0.98	1 infections, 243 procedures	0.98
Q1 2016 - Q4 2016 Result 2 infections, 350 procedures Rating SIR: 1.72	2 infections, 350 procedures	1.72
Q1 2015 - Q4 2015 Result 1 infections, 384 procedures Rating SIR: 0.41	1 infections, 384 procedures	0.41
Q1 2014 - Q4 2014 Result 1 infections, 388 procedures Rating SIR: 0.38	1 infections, 388 procedures	0.38
Q3 2013 - Q2 2014 Result 1 infections, 406 procedures Rating SIR: 0.35	1 infections, 406 procedures	0.35
Q3 2012 - Q2 2013 Result 1 infections, 352 procedures Rating SIR: 0.46	1 infections, 352 procedures	0.46
Q3 2011 - Q2 2012 Result 1 infections, 337 procedures Rating SIR: 0.54	1 infections, 337 procedures	0.54
Q3 2010 - Q2 2011 Result 2 infections, 414 procedures Rating SIR: 0.88	2 infections, 414 procedures	0.88
Coronary Artery Bypass Graft Surgery Q1 2020 - Q4 2020 Result 0 infections, 78 procedures ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 78 procedures ¹¹⁸	N/A ¹¹⁸
Description Surgical Site Infections Associated with Coronary Artery Bypass Graft Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2019 - Q4 2019 Result 1 infections, 84 procedures ¹¹⁴ Rating SIR: N/A ¹¹⁴	1 infections, 84 procedures ¹¹⁴	N/A ¹¹⁴
Q1 2018 - Q4 2018 Result 2 infections, 121 procedures Rating SIR: 1.89	2 infections, 121 procedures	1.89
Q1 2016 - Q4 2016 Result 0 infections, 86 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 86 procedures ¹⁵³	N/A ¹⁵³
Q1 2015 - Q4 2015 Result 1 infections, 92 procedures Rating SIR: 0.90	1 infections, 92 procedures	0.90
Q1 2014 - Q4 2014 Result 0 infections, 134 procedures Rating SIR: 0.00	0 infections, 134 procedures	0.00
Q3 2013 - Q2 2014 Result 0 infections, 130 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 130 procedures ¹¹⁷	0.00 ¹¹⁷
Q3 2012 - Q2 2013 Result 3 infections, 114 procedures Rating SIR: 2.45	3 infections, 114 procedures	2.45
Q3 2011 - Q2 2012 Result 0 infections, 105 procedures ⁴⁶ Rating SIR: 0.00 ⁴⁶	0 infections, 105 procedures ⁴⁶	0.00 ⁴⁶
Q3 2010 - Q2 2011 Result 2 infections, 124 procedures Rating SIR: 1.71	2 infections, 124 procedures	1.71